null Centre for Outcomes Research and Evaluation (CORE) - GUEST Speaker Seminar (October 9, 2018)

Randomized trials versus “real world” data? Why do they differ?

Learning Objectives
Using as examples biologics and new targeted synthetics in the management of rheumatoid arthritis
  • Understand differences between randomized trials for regulatory approval and real-world studies;
  • Describe why the results of real-world trials and registries differ from those of regulatory trials;
  • How can real-world studies guide practice using rheumatoid arthritis management as an example?

Presenter: Claire Bombardier, MD, FRCP(C)
Professor of Medicine, University of Toronto
Senior Scientist, TGRI, UHN
Rheumatologist, Mt Sinai Hospital

When: Tuesday, October 9, 2018 at noon

Where: 5252 Boulevard de Maisonneuve West, 3rd Floor (3B kitchen)

Information: CORE 514-934-1934 ext. 48292 or

The presentation will be delivered in English.